Abstract
In this study, analogues of olomoucine, a previously described plant cytokinin analogue with cyclin-dependent kinase (CDK) inhibitory activity, were investigated for effect on CDK1 and CDK2 and for effect on cell proliferation. Eight new compounds exhibit stronger inhibitory activity on CDK1 and CDK2 and on cell proliferation than olomoucine. Some active compounds showed low inhibition of proliferation of normal myeloid growth. Improvement of inhibitory activity of known compounds with a C6-benzylamino group was brought about by substitution with one hydroxyl. Also, new C2 substituents associated with inhibitory activity on CDK and on cell proliferation are described. There was a significant correlation between effect on CDK and antiproliferative effect on the KG1 and Molt3 cell lines and on primary human lymphocytes, strongly suggesting that at least part of the antiproliferative effect of cytokinin analogues was due to inhibition of CDK activity. Cytokinin analogues induced apoptosis in a time- and concentration-dependent manner and changes in cell cycle distribution. The antiproliferative and pro-apoptotic effects of plant cytokinin analogues suggest that they are a new class of cytostatic agents and that they may find an application in the chemotherapy of cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Miller CO, Skoog F, Saltza MH, von Strong FM . Kinetin, a cell division factor from deoxyribonucleic acid J Cell Biol 1955 77: 1329–1334
Strnad M . The aromatic cytokinins Plant J 1997 101: 674–688
Riou-Khamlichi C, Huntley R, Jacqmard A, Murray JAH . Cytokinin activation of Arabidopsis cell division through a D-type cyclin Science 1999 283: 1541–1544
Laureys F, Smets R, Lenjou M, Van Bockstaele D, Inze D, Van Onckelen H . A low content in zeatin type cytokinins is not restrictive for the occurrence of G1/S transition in tobacco BY-2 cells FEBS Lett 1999 460: 123–128
Meijer L, Pondaven P . Cyclic activation of histone H1 kinase during sea urchin egg mitotic divisions Exp Cell Res 1988 174: 116–129
Rialet V, Meijer L . A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates Anticancer Res 1991 11: 1581–1590
Neant I, Guerrier P . 6-Dimethylaminopurine blocks starfish oocyte maturation by inhibiting a relevant protein kinase activity Exp Cell Res 1988 176: 68–79
Vesely J, Havlicek L, Strnad M, Blow JJ, Donella DA, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S, Meijer L . Inhibition of cyclin-dependent kinases by purine analogues Eur J Biochem 1994 224: 771–786
Abraham RT, Acquarone M, Andersen A, Asensi A, Belle R, Berger F, Bergounioux C, Brunn G, Buquet FC, Fagot D, Glab N, Goudeau H, Goudeau M, Guerrier P, Houghton P, Hendriks H, Kloareg B, Lippai M, Marie D, Maro B, Meijer L, Mester J, Mulner-Lorillon O, Poulet S, Schierenberg E, Schutte B, Vaulot D, Verlhac M . Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases Biol Cell 1995 83: 105–120
Schutte B, Nieland L, van Engeland M, Henfling ME, Meijer L, Ramaekers FC . The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics Exp Cell Res 1997 236: 4–15
Ongkeko W, Ferguson DJ, Harris AL, Norbury C . Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage J Cell Sci 1995 108: 2897–2904
Hajduch M, Kolar Z, Novotny R, Hanus J, Mihal V, Hlobilkova A, Noskova V, Strnad M . Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine Anticancer Drugs 1997 8: 1007–1013
De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH . Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine Eur J Biochem 1997 243: 518–526
Schulze-Gahmen U, Brandsen J, Jones HD, Morgan DO, Meijer L, Vesely J, Kim SH . Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine Proteins 1995 22: 378–391
Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP . Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5 Eur J Biochem 1997 243: 527–536
Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, Leclerc S, Meijer L, Kim SH, Lockhart DJ, Schultz PG . Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors Science 1998 281: 533–538
Sherr CJ . Cancer cell cycles Science 1996 274: 1672–1677
Hall M, Peters G . Genetic alterations of cyclins, cyclin-dependent kinases, and CDK inhibitors in human cancer Adv Cancer Res 1996 68: 67–108
Garrett MD, Fattaey A . CDK inhibition and cancer therapy Curr Opin Genet Dev 1999 9: 104–111
Koeffler HP, Golde DW . Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity Science 1978 200: 1153–1154
Minowada J, Onuma T, Moore GE . Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes J Natl Cancer Inst 1972 49: 891–895
Havlicek L, Hanus J, Vesely J, Leclerc S, Meijer L, Shaw G, Strnad M . Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds J Med Chem 1997 40: 408–412
Stewart CC, Steinkamp JA . Quantitation of cell concentration using the flow cytometer Cytometry 1982 2: 238–243
Schlenke P, Frohn C, Kluter H, Saballus M, Hammers HJ, Zajac SR, Kirchner H . Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres Cytometry 1998 33: 310–317
Buhring HJ, Ullrich A, Schaudt K, Muller CA, Busch FW . The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells Leukemia 1991 5: 854–860
Weekx SF, Van Bockstaele DR, Plum J, Moulijn A, Rodrigus I, Lardon F, De Smedt M, Nijs G, Lenjou M, Loquet P, Berneman ZN, Snoeck HW . CD34++ CD38− and CD34+CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source Exp Hematol 1998 26: 1034–1042
Smith C, Gasparetto C, Collins N, Gillio A, Muench MO, O'Reilly RJ, Moore MA . Purification and partial characterization of a human hematopoietic precursor population Blood 1991 77: 2122–2128
Snoeck HW, Van Bockstaele DR, Nys G, Lenjou M, Lardon F, Haenen L, Rodrigus I, Peetermans ME, Berneman ZN . Interferon gamma selectively inhibits very primitive CD342+CD38− and not more mature CD34+CD38+ human hematopoietic progenitor cells J Exp Med 1994 180: 1177–1182
Lizard G, Fournel S, Genestier L, Dhedin N, Chaput C, Flacher M, Mutin M, Panaye G, Revillard JP . Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis Cytometry 1995 21: 275–283
Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z . Induction of DNA strand breaks associated with apoptosis during treatment of leukemias Leukemia 1993 7: 659–670
Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z . The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents Cancer Res 1993 53: 3186–3192
Chang YT, Gray NS, Rosania GR, Sutherlin DP, Kwon S, Norman TC, Sarohia R, Leost M, Meijer L, Schultz PG . Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors Chem Biol 1999 6: 361–375
Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R, Favaudon V . Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors Bioorg Med Chem 1999 7: 1281–1293
Clark C, Woodson MM, Nagasawa HT . Inhibition of lymphocyte proliferation by amantadine and its isomer, 2-aminoadamantane; impact on Lyt-2+ T cells while sparing L3T4+ T cells Immunopharmacology 1991 21: 41–50
Sedlacek H . Mechanisms of action of flavopiridol Crit Rev Oncol Hematol 2001 38: 139–170
Losiewicz MD, Carlson BA, Kaur G, Sausville EA, Worland PJ . Potent inhibition of CDC2 kinase activity by the flavonoid L86–8275 Biochem Biophys Res Commun 1994 201: 589–595
Senderowicz AM, Sausville EA . Preclinical and clinical development of cyclin-dependent kinase modulators J Natl Cancer Inst 2000 92: 376–387
Meijer L . Chemical inhibitors of cyclin-dependent kinases Trends Cell Biol 1996 6: 393–397
Meijer L, Leclerc S, Leost M . Properties and potential applications of chemical inhibitors of cyclin-dependent kinases Pharmacol Ther 1999 82: 279–284
Acknowledgements
This work was supported by the Concerted Research Action (GOA No. 21/1996) of the University of Antwerp and by the Czech Government Research Agency grants (1301/02/0475 and MSM153100008 to MS). We thank Prof David Lane (Department of Biochemistry, University of Dundee, UK) for the gift of the baculoviruses. We thank Prof W Stevens, Dr P Vermeulen and R Salgado for help with the statistical analysis of the data.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vermeulen, K., Strnad, M., Kryštof, V. et al. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases. Leukemia 16, 299–305 (2002). https://doi.org/10.1038/sj.leu.2402378
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402378
Keywords
This article is cited by
-
Could the kinetin riboside be used to inhibit human prostate cell epithelial–mesenchymal transition?
Medical Oncology (2020)
-
Genetically modified organisms and risks of their introduction
Russian Journal of Plant Physiology (2005)
-
Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones
Leukemia (2004)